To directly assess whether the activation of the p53 pathway is associated with NPC and OPC loss, Ddx20 and p53 double-knockout mice (Nestin-Cre;Ddx20flox/flox;p53−/− mice) were generated. The gene discussed is TP53; the disease is nasopharyngeal carcinoma.